{"url_path":"/sec/inmb/8-k/2026-06-17/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1711754/0001213900-26-069611-index.html","accession_number":"0001213900-26-069611","cik":"0001711754","ticker":"INMB","issuer_name":"Inmune Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1711754/0001213900-26-069611-index.html","primary_entity_key":"0001711754","primary_entity_name":"Inmune Bio, Inc."},"word_count":218,"has_tables":true,"body_markdown":"** **\n\n**Item 5.07 Submission of Matters to a Vote of Security Holders.**\n\n** **\n\nAt the Annual Meeting, each share of the Company’s\ncommon stock was entitled to one vote per share. As of April 20, 2026, the record date for the Annual Meeting, 26,585,258 shares\nof common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders\nat the Annual Meeting is set forth below.\n\n** **\n\n**Proposal One: Election of Directors.**\n\n* *\n\nStockholders elected each of the following nominees\nas directors to hold office until the next meeting of the Company’s stockholders and until his or her successor is elected and qualified.\n\n \n\nNominee \nVotes For  \nVotes\nWithheld  \nBroker\nNon-Votes \n\nDavid Moss \n 6,834,995  \n 2,120,682  \n 8,501,317 \n\nJ. Kelly Ganjei \n 5,955,609  \n 3,000,068  \n 8,501,317 \n\nTim Schroeder \n 6,622,916  \n 2,332,761  \n 8,501,317 \n\nScott Juda, JD \n 7,508,310  \n 1,447,367  \n 8,501,317 \n\nMarcia Allen \n 6,342,910  \n 2,612,767  \n 8,501,317 \n\n \n\n1\n\n** **\n\n**Proposal Two: Ratification of Appointment of\nIndependent Auditor.**\n\n** **\n\nStockholders approved the ratification of the appointment\nof CBIZ CPAs P.C. as the Company’s independent auditors for the fiscal year ending December 31, 2026.\n\n \n\nFor \nAgainst \nAbstentions \nBroker Non-Votes\n\n17,293,255 \n107,064 \n56,675 \n0\n\n \n\n**Proposal Three: Approval of the Third Amended\nand Restated INmune Bio Inc. 2021 Stock Incentive Plan.**\n\n \n\nAs noted above, the stockholders approved the Amended\nPlan.\n\n \n\n**For**\n \n**Against**\n \n**Abstentions**\n \n**Broker Non-Votes**\n\n6,085,086\n \n2,775,224\n \n95,367\n \n8,501,317"}